Item Details
Oman Launches OMR 6.5 Million Radiopharmaceutical Facility
On 8 November, Oman Investment Authority launched the Oman Nucleus project with an estimated investment of OMR 6.5 million to produce radiopharmaceuticals for diagnosis and treatment. The project creates opportunities in medical equipment, laboratory systems and pharmaceutical supply chains. HPC can help identify qualified healthcare suppliers and technical partners.
Get in Touch
We’ll get back to you shortly.